THESEUS PHARMACEUTICALS INC (THRX) Earnings History & Surprises
NASDAQ:THRX • US88369M1018
4.06 USD
0 (0%)
At close: Feb 13, 2024
4.08 USD
+0.02 (+0.49%)
After Hours: 2/13/2024, 8:11:21 PM
Past quarterly earnings results for THESEUS PHARMACEUTICALS INC (THRX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Release DateMar 7, 2024
PeriodQ4 / 2023
EPS Estimate-$0.30
Revenue Estimate
Last Reported
Release DateNov 17, 2023
PeriodQ3 / 2023
EPS Reported-$0.31
EPS Surprise 15.58%
Revenue Surprise %
Beat Rate
38%
EPS and Revenuebeats vs estimates
Quarterly Earnings Results
EPS & Revenue History (USD)
Actual vs estimated values, surprises, q2q growth and acceleration numbers for recent quarters.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2023 | -0.31 | -0.37 | 15.58% | 18.42% | - | - | ||
| Q2 2023 | -0.34 | -0.37 | 7.48% | -13.33% | - | - | ||
| Q1 2023 | -0.34 | -0.43 | 20.47% | -25.93% | - | - | ||
| Q4 2022 | -0.35 | -0.45 | 22.60% | -45.83% | - | - | ||
| Q3 2022 | -0.38 | -0.35 | -9.57% | 92.64% | - | - | ||
| Q2 2022 | -0.30 | -0.30 | 0.64% | - | - | - | ||
| Q1 2022 | -0.27 | -0.27 | 0.11% | - | - | - | ||
| Q4 2021 | -0.24 | -0.23 | -4.58% | - | - | - | ||
| Q3 2021 | -5.16 | -0.25 | -1,986.11% | - | - | - | ||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
4
Average EPS beat (4)
16.53%
Max EPS beat (4)
22.60%
Min EPS beat (4)
7.48%
Revenue beat statistics
Revenue beat (4)
N/A
Average Revenue beat (4)
N/A
Max Revenue beat (4)
N/A
Min Revenue beat (4)
N/A
Analysis
In the last 4 quarters, THRX has consistently beaten EPS estimates in all releases
In the last 4 quarters, THRX has beaten the EPS estimates by 16.5% on average.
THESEUS PHARMACEUTICALS INC / THRX Earnings FAQ
When did THESEUS PHARMACEUTICALS INC (THRX) report earnings last quarter?
THESEUS PHARMACEUTICALS INC (THRX) last reported earnings on 11/17/2023.
Did THRX stock beat earnings estimates in the most recent quarter?
THESEUS PHARMACEUTICALS INC (THRX) beat EPS estimates and missed revenue estimates in the most recent quarter.
How often does THESEUS PHARMACEUTICALS INC (THRX) beat earnings estimates?
In the last 4 quarters, THESEUS PHARMACEUTICALS INC (THRX) has beaten EPS estimates in 4 out of 4 releases.